Last reviewed · How we verify
Group morphine
At a glance
| Generic name | Group morphine |
|---|---|
| Also known as | intrathecal morphine, Morphine hydrochloride,, Kadian, Control Group, Morphine sulphate 10mg/ml |
| Sponsor | Ondokuz Mayıs University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Examining Analgesic Synergy and Efficacy in Trauma Care (PHASE4)
- Intercostal Nerve Cryoablation Versus Epidural Analgesia for Nuss Repair of Pectus Excavatum (NA)
- Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy (PHASE4)
- Phase II Clinical Study of the Efficacy and Safety of HSK55718 in the Treatment of Abdominal Postoperative Pain (PHASE2)
- Comparison of Intrathecal Morphine and Rectus Sheath Block for Postoperative Pain Management After Lower Abdominal Surgery With Midline Incision (NA)
- Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine Surgery
- Effect of CYP2D6 on Perioperative Analgesia of Oxycodone in Elderly Patients
- Analgesic Techniques for Robotic Prostatectomy Procedures (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Group morphine CI brief — competitive landscape report
- Group morphine updates RSS · CI watch RSS
- Ondokuz Mayıs University portfolio CI